Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Uni-bio Science Group

Uni-bio Science Group
2001 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
00690 STOCK SYMBOL
$0.03 SHARE PRICE (As of Tuesday Closing)
Description

Uni-Bio Science Group Ltd is a biopharmaceutical company. It is engaged in the research, development, production, and commercialization of biopharmaceuticals for the healthcare market. Its business activity is functioned through Chemical Pharmaceutical and Biological Pharmaceutical Products divisions. The In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of chemical products such as Pinapu, among others. The In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological products such as GeneTime and GeneSoft, among others. Pipeline product segment consists of industrialisation of pipeline pharmaceutical products.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Distributors (Healthcare)
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Room 3006, 30th Floor
  • 60 Wyndham Street
  • Hong Kong
  • Hong Kong

+852 3102 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Uni-bio Science Group’s full profile, request a free trial.

Uni-bio Science Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$163M $0.03 12.4M 6.41B

Uni-bio Science Group Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 93,460 65,277 114,024 89,354
Revenue 22,058 17,257 20,080 18,869
EBITDA (3,834) (14,993) (31,798) (3,458)
Net Income (3,883) (17,679) (35,842) (7,178)
Total Assets 39,315 30,954 49,940 64,130
Total Debt 1,970 1,717 0 1,417
Public Fundamental Data provided by Morningstar, Inc. disclaimer